FR2896163B1 - Produit utilise en tant que complement alimentaire ou medicament, destine a reduire la prise de lipides dans l'alimentation, et utilisation de ce produit. - Google Patents

Produit utilise en tant que complement alimentaire ou medicament, destine a reduire la prise de lipides dans l'alimentation, et utilisation de ce produit.

Info

Publication number
FR2896163B1
FR2896163B1 FR0650178A FR0650178A FR2896163B1 FR 2896163 B1 FR2896163 B1 FR 2896163B1 FR 0650178 A FR0650178 A FR 0650178A FR 0650178 A FR0650178 A FR 0650178A FR 2896163 B1 FR2896163 B1 FR 2896163B1
Authority
FR
France
Prior art keywords
food
product
lipid
reducing
product used
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0650178A
Other languages
English (en)
Other versions
FR2896163A1 (fr
Inventor
Hugues Chevassus
Pierre Petit
Eric Renard
Florence Galtier
Anne Farret
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LEGRAS LAB
Centre Hospitalier Universitaire de Montpellier CHUM
Original Assignee
LEGRAS LAB
Centre Hospitalier Universitaire de Montpellier CHUM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LEGRAS LAB, Centre Hospitalier Universitaire de Montpellier CHUM filed Critical LEGRAS LAB
Priority to FR0650178A priority Critical patent/FR2896163B1/fr
Publication of FR2896163A1 publication Critical patent/FR2896163A1/fr
Application granted granted Critical
Publication of FR2896163B1 publication Critical patent/FR2896163B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0650178A 2006-01-18 2006-01-18 Produit utilise en tant que complement alimentaire ou medicament, destine a reduire la prise de lipides dans l'alimentation, et utilisation de ce produit. Expired - Fee Related FR2896163B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0650178A FR2896163B1 (fr) 2006-01-18 2006-01-18 Produit utilise en tant que complement alimentaire ou medicament, destine a reduire la prise de lipides dans l'alimentation, et utilisation de ce produit.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0650178A FR2896163B1 (fr) 2006-01-18 2006-01-18 Produit utilise en tant que complement alimentaire ou medicament, destine a reduire la prise de lipides dans l'alimentation, et utilisation de ce produit.

Publications (2)

Publication Number Publication Date
FR2896163A1 FR2896163A1 (fr) 2007-07-20
FR2896163B1 true FR2896163B1 (fr) 2011-04-15

Family

ID=36956200

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0650178A Expired - Fee Related FR2896163B1 (fr) 2006-01-18 2006-01-18 Produit utilise en tant que complement alimentaire ou medicament, destine a reduire la prise de lipides dans l'alimentation, et utilisation de ce produit.

Country Status (1)

Country Link
FR (1) FR2896163B1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060159746A1 (en) * 2003-03-18 2006-07-20 Troup John P Compositions comprising fatty acids and amino acids
US7976880B2 (en) * 2003-06-04 2011-07-12 Ramaswamy Rajendran Pregnane glycoside compositions and Caralluma extract products and uses thereof
US20060057228A1 (en) * 2004-07-09 2006-03-16 Pure World Botanicals, Inc. Weight loss composition

Also Published As

Publication number Publication date
FR2896163A1 (fr) 2007-07-20

Similar Documents

Publication Publication Date Title
USD616090S1 (en) Sealing device for medicine container or medical apparatus
USD628363S1 (en) Pair of sleeves
MY148723A (en) Use of pinolenic acid for the treatment of obesity
IL190227A (en) Phenyl derivatives - [1,2,4] - oxadiazole - 5 - On with a phenyl group, their use in medicine, pharmaceuticals containing them, and a process for preparing the pharmaceutical preparations
WO2009071690A3 (fr) Dérivés d'oxindole à double substitution en positions 5 et 6 et leur utilisation pour traiter des maladies liées à la vasopressine
BRPI0814981A2 (pt) Produto alimentício líquido que pode ser batido, produto batido, e, produto pré-batido.
MX2007013301A (es) Agente profilactico/terapeutico para la anormalidades del metabolismo del azucar/lipidos.
WO2009134086A3 (fr) Préparation pharmaceutique pour le traitement d'une maladie cardiovasculaire
WO2008124081A3 (fr) Dissolution rapide de produits de combinaison
BRPI0819342A2 (pt) Produto medicinal ou líquido nutricional administrável oralmente, produto hidratante líquido administrável oralmente, produto alimentício de textura modificada, assim como o uso de ditos produtos.
FR2909879B1 (fr) Utilisation d'un heptapeptide a activite anxiolytique pour la preparation de medicaments et de complements alimentaires
ZA201001117B (en) The application of 5-methyl-1,3-benzenediol or derivatives thereof in the preparation of medicines and functional foods for treatment or prevention of depression
PL2121277T3 (pl) Sposób wytwarzania opakowań dla produktów kosmetycznych, leczniczych, farmaceutycznych i tym podobnych
FR2896163B1 (fr) Produit utilise en tant que complement alimentaire ou medicament, destine a reduire la prise de lipides dans l'alimentation, et utilisation de ce produit.
EP1847244A4 (fr) Agent attenuant le syndrome metabolique et medicament, complement, aliment fonctionnel et additif alimentaire contenant celui-ci
EP1847266A4 (fr) Agent ameliorant le syndrome metabolique et medicament, complement, alicaments et additif alimentaire en contenant
DE602008002027D1 (de) Additionssalze von Hemmern des Angiotensin konvertierenden Enzyms mit NO abgebenden Säuren, Verfahren zu ihrer Herstellung und die sie enthaltenden pharmazeutischen Zusammensetzungen
FR2896690B1 (fr) Utilisation de l'enantiomere(s) de la mequitazine pour la preparation d'un medicament, tout en limitant la toxicite genomique
WO2009027843A3 (fr) Techniques pour définir l'indication d'un nouveau composé et pour redéfinir l'indication d'un médicament
JP2011121885A5 (fr)
FR2861301B1 (fr) Utilisation du derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement du syndrome metabolique.
RU2005139433A (ru) Способ комплексной коррекции дисбиоза кишечника с помощью жидкого пробиотика "нарине-форте" и пребиотика сиропа "фитолон" с хлорофиллом
WO2008108284A1 (fr) Inhibiteur de la production de rankl
Hastings The Role of Toxicology in Evaluating Marketing Applications for Prescription Drug Products in the United States
TH103323S (th) ภาชนะบรรจุสำหรับยา

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20140930